Cargando…

Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Shiina, Shuichiro, Maruyama, Hitoshi, Tobari, Maki, Yamashita, Tatsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386951/ https://www.ncbi.nlm.nih.gov/pubmed/37188999 http://dx.doi.org/10.1007/s12072-023-10533-w

Ejemplares similares

Ablation for Benign Liver Tumors: Current Concepts and Limitations
por: Maruyama, Hitoshi, et al.
Publicado: (2023)

Connection between HPS and ACLF: a solution of chaos?
por: Maruyama, Hitoshi, et al.
Publicado: (2021)

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
por: Rios, Rafael S., et al.
Publicado: (2021)

Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosis
por: Maruyama, Hitoshi, et al.
Publicado: (2022)

Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
por: Tovo, Cristiane Valle, et al.
Publicado: (2023)

Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
por: Yu, Junjie, et al.
Publicado: (2023)

Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
por: Ramai, Daryl, et al.
Publicado: (2021)

Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma
por: Hymel, Emma, et al.
Publicado: (2022)

Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
por: Kumar, Rahul, et al.
Publicado: (2020)

Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non‐alcoholic steatohepatitis model
por: Shimizu, Yoshio, et al.
Publicado: (2020)

Dual-specificity phosphatase 3 deletion promotes obesity, non-alcoholic steatohepatitis and hepatocellular carcinoma
por: Jacques, Sophie, et al.
Publicado: (2021)

Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention
por: Ip, Blanche C., et al.
Publicado: (2013)

Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Kessler, Sonja M., et al.
Publicado: (2014)

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
por: Weinmann, Arndt, et al.
Publicado: (2015)

Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
por: Hartmann, Phillipp, et al.
Publicado: (2022)

Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: Brazilian Survey
por: Alves, Venancio Avancini Ferreira, et al.
Publicado: (2016)

Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management
por: Salomone, Federico, et al.
Publicado: (2015)

Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
por: Cholankeril, George, et al.
Publicado: (2017)

Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis
por: Liakina, Valentina, et al.
Publicado: (2022)

Free fatty acid-based low-impedance liver image: a characteristic appearance in nonalcoholic steatohepatitis (NASH)
por: Maruyama, Hitoshi, et al.
Publicado: (2020)

Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas
por: Kakehashi, Anna, et al.
Publicado: (2017)

Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma
por: Takakura, Kazuki, et al.
Publicado: (2019)

13 CHEMOPREVENTIVE EFFECT OF STATIN ON HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC STEATOHEPATITIS PATIENTS WITH CIRRHOSIS
por: Al-Yaman, Wael A., et al.
Publicado: (2021)

Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases
por: Safaei, Akram, et al.
Publicado: (2016)

Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?
por: Jeong, Soung Won
Publicado: (2020)

The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma
por: Shimomura, Yasuyuki, et al.
Publicado: (2017)

p27 Is a Critical Prognostic Biomarker in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma
por: Matsuda, Yasunobu, et al.
Publicado: (2013)

Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis – epidemiology, risk factors, clinical implications and treatment
por: Straś, Wojciech, et al.
Publicado: (2020)

Role of Asxl2 in non-alcoholic steatohepatitis-related hepatocellular carcinoma developed from diabetes
por: Hu, Zhiqiu, et al.
Publicado: (2021)

A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Krizanac, Marinela, et al.
Publicado: (2021)

Novel Perspectives in Immune Checkpoint Inhibitors and the Management of Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma
por: Chan, Landon L., et al.
Publicado: (2022)

Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics
por: Sydor, Svenja, et al.
Publicado: (2022)

All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma
por: van Mourik, Hester, et al.
Publicado: (2022)

Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
por: Ocker, Matthias
Publicado: (2020)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

A New Rodent Model of Non-Alcoholic Steatohepatitis and Metabolic Syndrome
por: Romeiro, Fernando Gomes, et al.
Publicado: (2019)

Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model
por: Takegoshi, Kai, et al.
Publicado: (2017)

Research landscape and frontiers of non-alcoholic steatohepatitis-associated hepatocellular carcinoma: a bibliometric and visual analysis
por: Gao, Bowen, et al.
Publicado: (2023)

Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas
por: Tian, Ying, et al.
Publicado: (2020)

Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis
por: Kuo, Joseph, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0mh9hfi119shcklgkd5ee6vf7q